StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Bernstein SocGen Group Reiterates Outperform Rating on CVS Health (CVS), 'strong quarter'
May 6, 2026 9:23 AM
Bernstein SocGen Group analyst Lance Wilkes reiterated an Outperform rating and $94.00 price target on CVS Health (NYSE: CVS).The analyst ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst Comments
